Evolent Health (EVH) Capital Expenditures (2015 - 2026)

Evolent Health's Capital Expenditures history runs 12 years deep, the most recent figure standing at $6.4 million for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 25.47% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $31.9 million, a 13.35% increase from a year earlier, with the FY2025 full-year figure at $34.1 million, up 36.94% from the prior year.
• Capital Expenditures fell to $6.4 million in Q1 2026 per EVH's latest filing, from $7.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $10.7 million in Q4 2022 and bottomed at $5.3 million in Q1 2024.
• The 5-year median for Capital Expenditures is $7.8 million (2025), against an average of $7.8 million.
• Across the five-year window, Capital Expenditures soared 65.79% in 2022 and slumped 43.67% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at $10.7 million in 2022, then slumped by 43.67% to $6.1 million in 2023, then grew by 1.64% to $6.2 million in 2024, then climbed by 26.17% to $7.8 million in 2025, then fell by 17.46% to $6.4 million in 2026.
• Per Business Quant, the three latest EVH Capital Expenditures figures stand at $6.4 million (Q1 2026), $7.8 million (Q4 2025), and $9.0 million (Q3 2025).